| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA663133 | B | Binding energy to Streptococcus faecium dihydrofolate reductase | Enterococcus faecium | 68 | ALA1122106 | single protein format | Scientific Literature | |
| 2. | ALA663137 | B | Binding energy against Streptococcus faecium dihydrofolate reductase | Enterococcus faecium | 68 | ALA1121631 | single protein format | Scientific Literature | |
| 3. | ALA666235 | B | The concentration required to inhibit dihydrofolate reductase in rat liver | 107 | ALA1122689 | tissue-based format | Scientific Literature | ||
| 4. | ALA666236 | B | Inhibitory activity against dihydrofolate reductase of rat liver | 39 | ALA1121851 | assay format | Scientific Literature | ||
| 5. | ALA666238 | B | Concentration required for inhibition of rat liver dihydrofolate reductase (DHFR) | 103 | ALA1122259 | assay format | Scientific Literature | ||
| 6. | ALA716726 | F | Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 40 mg/kg subcutaneous dose; 3 cured at 60 days post infection | Mus musculus | 1 | ALA1123553 | organism-based format | Scientific Literature | |
| 7. | ALA716730 | F | Antimalarial activity against Plasmodium berghei strain in mice (Mus musculus) by parentral route and change in mean survival time in days was determined at 640 mg/kg subcutaneous dose; 5 cured at 60 days postinfection | Mus musculus | 2 | ALA1123553 | organism-based format | Scientific Literature | |
| 8. | ALA716733 | F | Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 80 mg/kg subcutaneous dose; 5 cured at 60 days post infection | Mus musculus | 2 | ALA1123553 | organism-based format | Scientific Literature | |
| 9. | ALA716735 | F | Antimalarial activity against Plasmodium berghei strain in mice (Mus musculus) by parentral route and change in mean survival time in days was determined at 160 mg/kg subcutaneous dose; 5 cured at 60 days postinfection | Mus musculus | 2 | ALA1123553 | organism-based format | Scientific Literature | |
| 10. | ALA717340 | F | Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 320 mg/kg subcutaneous dose; 5 cured at 60 days post infection | Mus musculus | 2 | ALA1123553 | organism-based format | Scientific Literature | |
| 11. | ALA1217000 | F | Antimicrobial activity against Plasmodium falciparum | Plasmodium falciparum | 630 | ALA1212812 | organism-based format | Scientific Literature | |
| 12. | ALA1794553 | F | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | Homo sapiens | 58,172 | ALA1201862 | cell-based format | PubChem BioAssays | |
| 13. | ALA1794584 | F | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | 63,980 | ALA1201862 | assay format | PubChem BioAssays | ||
| 14. | ALA1963972 | F | PUBCHEM_BIOASSAY: Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | 1,261 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 15. | ALA1963976 | F | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | 27,593 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 16. | ALA1963981 | F | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | 41,327 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 17. | ALA1963985 | F | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | 41,631 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 18. | ALA1963989 | F | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | 41,040 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 19. | ALA1963990 | F | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | 40,970 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 20. | ALA1963991 | F | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | 36,454 | ALA1201862 | cell-based format | PubChem BioAssays |
The page will load shortly, Thanks for your patience!